Other wet lab experimentations demonstrate the expression of TRIP13 as a specific signal for early events of pancreatic cancer, this proper positioning may enhance patient prognosis, and boosting targeted therapies in clinical settings. This evidence concerns the gene TRIP13 and familial pancreatic carcinoma.